UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17436

2023

Volltextzugriff (PDF)

Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients' Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays

International journal of molecular sciences, 2024-06, Vol.25 (13), p.6983

2024

Volltextzugriff (PDF)

Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes

International journal of molecular sciences, 2022-12, Vol.24 (1), p.463

2022

Volltextzugriff (PDF)

Venetoclax und Obinutuzumab bei unbehandelten komorbiden CLL-Patienten

InFo Hämatologie + Onkologie, 2019-09, Vol.22 (9), p.47-48

2019

Volltextzugriff (PDF)

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

Haematologica (Roma), 2009-01, Vol.94 (1), p.141-144

2009

Volltextzugriff (PDF)

Clinical Phase I Dose Escalation and Pharmacokinetic Study of High-Dose Chemotherapy with Treosulfan and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Advanced Malignancies

Clinical cancer research, 2000-11, Vol.6 (11), p.4209-4216

2000

Volltextzugriff (PDF)

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Acta oncologica, 2021-01, Vol.60 (1), p.24-27

2021

Volltextzugriff (PDF)

Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo

Molecular immunology, 2024-11, Vol.175, p.40-54

2024

Volltextzugriff (PDF)

Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.287-288

2022

Volltextzugriff (PDF)

Survival of Tumor Cells in Stem Cell Preparations and Bone Marrow of Patients with High-Risk or Metastatic Breast Cancer after Receiving Dose-intensive or High-Dose Chemotherapy

Clinical cancer research, 2001-06, Vol.7 (6), p.1582

2001

Volltextzugriff (PDF)

Tumorassoziierte Fatigue in der Palliativsituation

Frauenheilkunde up2date, 2017-04, Vol.11 (1), p.83-96

2017

Volltextzugriff (PDF)

Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management

Cancer, 1994-04, Vol.73 (8), p.2218-2222

1994

Volltextzugriff (PDF)

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Blood advances, 2023-03, Vol.7 (5), p.832-844

2023

Volltextzugriff (PDF)

Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer Society

Oncology research and treatment, 2016-10, Vol.39 (10), p.646-651

2016

Volltextzugriff (PDF)

Metronomic oral cyclophosphamide in patients with advanced solid tumors

Onkologie, 2012, Vol.35 (1-2), p.35-38

2012

Volltextzugriff (PDF)

Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients

Journal of fungi (Basel), 2020-03, Vol.6 (1), p.36

2020

Volltextzugriff (PDF)

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Blood, 2014-12, Vol.124 (21), p.3969-3969

2014

Volltextzugriff (PDF)

Analysis of the V617F Mutation of the JAK2- and the W515 Mutation of the MPL Gene in Patients with Chronic Myeloproliferative Disease (CMPD) Treated in an Outpatient Practice

Blood, 2007-11, Vol.110 (11), p.4631-4631

2007

Volltextzugriff (PDF)

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Blood, 2012-11, Vol.120 (21), p.2012-2012

2012

Volltextzugriff (PDF)

Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease

Oncology research and treatment, 2009-04, Vol.32 (4), p.191-195

2009

Volltextzugriff (PDF)

Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients

Blood, 2007-11, Vol.110 (11), p.2546-2546

2007

Volltextzugriff (PDF)

Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function

Anti-cancer drugs, 2002-09, Vol.13 (8), p.847-849

2002

Volltextzugriff (PDF)

Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy1

Clinical cancer research, 2001, Vol.7 (6), p.1582-1589

2001

Volltextzugriff (PDF)

Analysis of commercial CD34 control samples for quality assurance

Clinical laboratory (Heidelberg), 2002, Vol.48 (3-4), p.117

2002

Volltextzugriff (PDF)

High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer

Journal of cancer research and clinical oncology, 2001-04, Vol.127 (4), p.243-250

2001

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)

Sprache

Englisch
(51)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(35)
Humans
(26)
Female
(16)
Middle Aged
(16)
Male
(15)
Adult
(13)
Aged
(10)
Oncology
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Life Sciences
(7)
Biochemistry & Molecular Biology
(6)
Pediatrics
(6)
Aged, 80 And Over
(5)
Chemotherapy
(5)
Hematopoietic Stem Cell Transplantation
(5)
Chemistry
(4)
General & Internal Medicine
(4)
Hematology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture

Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients' Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays

Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes

Venetoclax und Obinutuzumab bei unbehandelten komorbiden CLL-Patienten

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

Clinical Phase I Dose Escalation and Pharmacokinetic Study of High-Dose Chemotherapy with Treosulfan and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Advanced Malignancies

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo

Survival of Tumor Cells in Stem Cell Preparations and Bone Marrow of Patients with High-Risk or Metastatic Breast Cancer after Receiving Dose-intensive or High-Dose Chemotherapy

Tumorassoziierte Fatigue in der Palliativsituation

Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer Society

Metronomic oral cyclophosphamide in patients with advanced solid tumors

Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Analysis of the V617F Mutation of the JAK2- and the W515 Mutation of the MPL Gene in Patients with Chronic Myeloproliferative Disease (CMPD) Treated in an Outpatient Practice

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease

Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients

Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function

Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy1

Analysis of commercial CD34 control samples for quality assurance

High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer

Suchergebnisse filtern